Cost-effectiveness analysis: From science to application

Medical Care

Volumn 43, Issue 7 SUPPL., 2005, Pages

  Berger, Marc L ^a   Teutsch, Steven ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Cost effectiveness; Formulary; Healthcare policy

Indexed keywords

COST BENEFIT ANALYSIS; ECONOMICS; EVIDENCE BASED MEDICINE; HEALTH CARE POLICY; MANAGEMENT; PHARMACOECONOMICS; REVIEW; STATISTICAL MODEL; UNITED STATES;

COST-BENEFIT ANALYSIS; ECONOMICS, PHARMACEUTICAL; EVIDENCE-BASED MEDICINE; HEALTH POLICY; MODELS, ECONOMETRIC; POLICY MAKING; UNITED STATES;

EID: 22944441580     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (15)

1. Format for Formulary Submissions. Alexandria, VA: Academy of Managed Care Pharmacy; October 2000.
2. Laupacis A. Incorporating economic evaluations into decision making: the Ontario experience. Med Care. 2005;43(suppl):II-15-II-19.
3. Aspinall SL, Good CB, Glassman PA, et al. The evolving use of cost-effectiveness analysis in formulary management within the Department of Veterans Affairs. Med Care. 2005;43(suppl):II-20-II-26.
4. Helfand M. Incorporating information about cost-effectiveness into evidence-based decision-making: the evidence-based practice center (EPC) model. Med Care. 2005;43(suppl):II-33-II-43.
5. Furberg C, Herrington D, Psaty B. Are drugs within a class interchangeable? Lancet. 1999;354:1202-1204.
6. DeMets D, Califf R. Lessons learned from recent cardiovascular clinical trials: parts 1 and 2. Circulation. 2003;106:746-751, 880-886.
7. Cannon CP, Braunwald E, McCabe CH, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med. 2004;350:1495-1504.
8. Neumann PJ. The arrival of economic evidence in managed care formulary decisions: the unsolicited request process. Med Care. 2005;43(suppl):II-27-II- 32.
9. Drummond M, Sculpher M. Common methodological flaws in economic evaluations. Med Care. 2005;43(suppl):II-5-II-14.
10. Sen A. Rationality and Freedom. Cambridge: Belknap Press of Harvard University Press; 2002.
11. Berger ML. The once and future application of cost-effectiveness analysis. Jt Comm J Qual Improv. 1999;25:455-461.
12. Arrow KJ. Social Choice and Individual Values. New York: Wiley; 1951.
13. Daniels N, Sabin J. Limits to health care: fair procedures, democratic deliberation, and the legitimacy problem for insurers. Philosophy and Public Affairs. 1997;26:303-350.
14. Teutsch SM, Berger ML, Weinstein MC. Comparative effectiveness: asking the right questions, choosing the right method. Health Aff (Millwood). 2005;24:128-132.
15. Gold MR, Siegel JE, Russell LB, et al. Cost-Effectiveness in Health and Medicine. New York: Oxford University Press; 1996.